Advertise with us
Clinical Group

International Journal of Clinical Endocrinology and Metabolism

    Abstract Open Access
    Research Article PTZAID: IJCEM-1-104

    Glutamic Acid Decarboxylase Autoantibodies Role in Reclassifying Diabetes of Adulthood in Basrah

    Abbas Ali Mansour*, Ammar Mohamd Saead Almomin, Ali Hussein Ali Alhamza

    Aim: To determine the prevalence and phenotypic characteristics of diabetes subtypes based on glutamic acid decarboxylase autoantibodies (GADA) status in those newly presented diabetic to the Al-Faiha Specialized Diabetes, Endocrine and Metabolism Center (FDEMC) in Basrah, Southern Iraq.

    Methods: The study design is cross-sectional and includes adult diabetic patients if they are free of insulin treatment for at least 6 months from diagnosis and to be 30 years of age and over from the period of January 2013 to March 2013.

    Results: Of our diabetics with age 30 years and more, 26.4% were GADA-positive. The only significantly higher variables seen more among GADA-positive diabetes groups were normal weight and current insulin uses. GADA-positivity was not associated with gender, age, BMI, family history, smoking, hypertension, duration of diabetes, or specific HbA1c in the current study.

    Conclusion: A quarter of adults diabetic in Basrah were GADA positive. GADA positivity means more likely to be normal weight diabetics and currently on insulin use.

    Published on: Jul 15, 2015 Pages: 13-16

    Full Text PDF Full Text HTML DOI: 10.17352/ijcem.000004

    Advertisements

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on IJCEM